These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 29467012

  • 1. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
    Han Y, Yan LF, Wang XB, Sun YZ, Zhang X, Liu ZC, Nan HY, Hu YC, Yang Y, Zhang J, Yu Y, Sun Q, Tian Q, Hu B, Xiao G, Wang W, Cui GB.
    BMC Cancer; 2018 Feb 21; 18(1):215. PubMed ID: 29467012
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S, Rui Q, Wang Y, Heo HY, Zou T, Yu H, Zhang Y, Wang X, Du Y, Wen X, Chen F, Wang J, Eberhart CG, Zhou J, Wen Z.
    Eur Radiol; 2018 May 21; 28(5):2115-2123. PubMed ID: 29234914
    [Abstract] [Full Text] [Related]

  • 4. Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.
    Sunwoo L, Choi SH, Park CK, Kim JW, Yi KS, Lee WJ, Yoon TJ, Song SW, Kim JE, Kim JY, Kim TM, Lee SH, Kim JH, Sohn CH, Park SH, Kim IH, Chang KH.
    J Magn Reson Imaging; 2013 Feb 21; 37(2):351-8. PubMed ID: 23023975
    [Abstract] [Full Text] [Related]

  • 5. Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status.
    Romano A, Calabria LF, Tavanti F, Minniti G, Rossi-Espagnet MC, Coppola V, Pugliese S, Guida D, Francione G, Colonnese C, Fantozzi LM, Bozzao A.
    Eur Radiol; 2013 Feb 21; 23(2):513-20. PubMed ID: 22875158
    [Abstract] [Full Text] [Related]

  • 6. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
    Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR.
    Neuroimage; 2010 Jan 15; 49(2):1398-405. PubMed ID: 19796694
    [Abstract] [Full Text] [Related]

  • 7. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
    Kanas VG, Zacharaki EI, Thomas GA, Zinn PO, Megalooikonomou V, Colen RR.
    Comput Methods Programs Biomed; 2017 Mar 15; 140():249-257. PubMed ID: 28254081
    [Abstract] [Full Text] [Related]

  • 8. Incremental Prognostic Value of ADC Histogram Analysis over MGMT Promoter Methylation Status in Patients with Glioblastoma.
    Choi YS, Ahn SS, Kim DW, Chang JH, Kang SG, Kim EH, Kim SH, Rim TH, Lee SK.
    Radiology; 2016 Oct 15; 281(1):175-84. PubMed ID: 27120357
    [Abstract] [Full Text] [Related]

  • 9. Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation.
    Yoon RG, Kim HS, Paik W, Shim WH, Kim SJ, Kim JH.
    Eur Radiol; 2017 Jan 15; 27(1):255-266. PubMed ID: 27048531
    [Abstract] [Full Text] [Related]

  • 10. MGMT Promoter Methylation Status in Initial and Recurrent Glioblastoma: Correlation Study with DWI and DSC PWI Features.
    Choi HJ, Choi SH, You SH, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Park CK, Park SH.
    AJNR Am J Neuroradiol; 2021 May 15; 42(5):853-860. PubMed ID: 33632732
    [Abstract] [Full Text] [Related]

  • 11. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
    Yuan G, Niu L, Zhang Y, Wang X, Ma K, Yin H, Dai J, Zhou W, Pan Y.
    J Neurooncol; 2017 May 15; 133(1):193-201. PubMed ID: 28516344
    [Abstract] [Full Text] [Related]

  • 12. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB, Guo F, Xu ZL, Li C, Wei W, Tian P, Liu TT, Liu L, Chen G, Ye J, Cheng G, Cui LB, Zhang HJ, Qin W, Yin H.
    J Magn Reson Imaging; 2018 May 15; 47(5):1380-1387. PubMed ID: 28926163
    [Abstract] [Full Text] [Related]

  • 13. The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.
    Shu C, Wang Q, Yan X, Wang J.
    Cancer Med; 2018 Aug 15; 7(8):3704-3712. PubMed ID: 29984907
    [Abstract] [Full Text] [Related]

  • 14. Adaptive fine-tuning based transfer learning for the identification of MGMT promoter methylation status.
    Schmitz E, Guo Y, Wang J.
    Biomed Phys Eng Express; 2024 Jul 30; 10(5):. PubMed ID: 39029475
    [Abstract] [Full Text] [Related]

  • 15. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
    Ahn SS, Shin NY, Chang JH, Kim SH, Kim EH, Kim DW, Lee SK.
    J Neurosurg; 2014 Aug 30; 121(2):367-73. PubMed ID: 24949678
    [Abstract] [Full Text] [Related]

  • 16. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
    Li ZC, Bai H, Sun Q, Li Q, Liu L, Zou Y, Chen Y, Liang C, Zheng H.
    Eur Radiol; 2018 Sep 30; 28(9):3640-3650. PubMed ID: 29564594
    [Abstract] [Full Text] [Related]

  • 17. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
    Korfiatis P, Kline TL, Coufalova L, Lachance DH, Parney IF, Carter RE, Buckner JC, Erickson BJ.
    Med Phys; 2016 Jun 30; 43(6):2835-2844. PubMed ID: 27277032
    [Abstract] [Full Text] [Related]

  • 18. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
    Wei J, Yang G, Hao X, Gu D, Tan Y, Wang X, Dong D, Zhang S, Wang L, Zhang H, Tian J.
    Eur Radiol; 2019 Feb 30; 29(2):877-888. PubMed ID: 30039219
    [Abstract] [Full Text] [Related]

  • 19. Confounding factors in diagnostics of MGMT promoter methylation status in glioblastomas in stereotactic biopsies.
    Weise LM, Harter PN, Eibach S, Braczynski AK, Dunst M, Rieger J, Bähr O, Hattingen E, Steinbach JP, Plate KH, Seifert V, Mittelbronn M.
    Stereotact Funct Neurosurg; 2014 Feb 30; 92(3):129-39. PubMed ID: 24776650
    [Abstract] [Full Text] [Related]

  • 20. Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis.
    Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ.
    AJNR Am J Neuroradiol; 2018 Aug 30; 39(8):1439-1445. PubMed ID: 30002055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.